Stock SIOX SIO GENE THERAPIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Sio Gene Therapies Inc. Nasdaq

Equities

SIOX

US8293991043

Delayed Nasdaq
Other stock markets
 15:58:58 2024-02-07 EST 		5-day change 1st Jan Change
0.478 USD +1.70% Intraday chart for Sio Gene Therapies Inc. +22.88% +29.19%
2023 Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index CI
2023 Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sio Gene Therapies Ends Gene Therapy Program for Parkinson's Disease, Names New CEO
MT
Sio Gene Therapies Inc. Announces Executive Changes
CI
Sio Gene Therapies Inc. Appoints David Nassif, J.D. to Its Board of Directors
CI
Sio Gene Therapies : Chief Research and Development Officer Gavin Corcoran to Leave Next Month; Unveils Chief Medical Officer Role
MT
Sio Gene Therapies Inc. Announces Executive Changes
CI
Axovant Sciences Announces Formation of Arvelle Therapeutics; Mark Altmeyer to Step Down as Chief Commercial Officer
CI
Axovant Sciences Ltd. Announces Management Changes
CI
Axovant Sciences Announces Changes to Board of Directors
CI
Axovant Sciences Ltd. Announces Management Changes
CI
Axovant Sciences Announces Management Changes
CI
Axovant Sciences Ltd Appoints Tony Vernon to its Board of Directors
CI
Axovant Sciences Ltd Appoints Kate Falberg to its Board of Directors
CI
Axovant Sciences Ltd Appoints Marion Mccourt as President, Chief Operating Officer
CI
Axovant Sciences Ltd. Appoints Gary P. Pisano to Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SIOX Stock
  4. SIOX Stock
  5. News Sio Gene Therapies Inc.
  6. Insiders